South Korea

Celltrion Healthcare is on track to raise W1tr ($882.4m) as it eyes the top of guidance for its IPO, taking advantage of strong demand from international long-only funds, according to a source close to the deal.

Korea Gas Corp took advantage of an improvement in market sentiment after US Federal Reserve chair Janet Yellen spoke to Congress, sealing an $800m dual tranche deal on Thursday.

CJ CheilJedang Corp sold all of its stake in Samsung Life Insurance Co through an overnight block this week, raising W357.7bn ($314.2m) after the bookrunners managed to move investors up to the middle of the price range.

Korea Gas Corp opened books for a dual tranche dollar deal on Thursday, more than a month after wrapping up a roadshow in Europe. Industrial Bank of Korea and Doosan Infracore, meanwhile, have mandated banks for new dollar transactions.

CJ CheilJedang Corp has raised W357.7bn ($312.2m) after selling its entire position in Samsung Life Insurance Co through an overnight block, with the bookrunners managing to move up investors to the middle of the price range.

South Korea’s Nonghyup Bank reeled in investors for its $500m five year bond at the start of the week, pricing the notes flat to its existing curve.

South Korean food company CJ CheilJedang Corp has hit the equities market to clean up its position in Samsung Life Insurance Co with a view to raise up to W361.4bn ($313.8m).

South Korean agricultural lender Nonghyup Bank began marketing a five year dollar transaction on Monday morning, returning to the debt market after about nine months.

Two shareholders pared down their stakes through separate block trades on Thursday as the stocks hit one-year highs, punctuating a relatively quiet week for overnight bookbuilds in Asia.

Posco has launched a block sale of KB Financial Group's shares, and is looking to raise up to W443.5bn ($383.0m), according to a term sheet for the deal.

Korea Development Bank (KDB) added a dash of variety to Asia’s green market on Tuesday with its inaugural $300m deal, finding support from a combination of dedicated green funds, as well as conventional investors. Typical of issuers from South Korea, the policy bank did not pay any new issue premium for its fundraising.

Roadshows have begun for the IPO of Celltrion Healthcare, the South Korean marketing affiliate of Celltrion, in a deal that can reach W1.008tr ($897m) if priced at the top of the range.